Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
The Journal of Steroid Biochemistry and Molecular Biology|November 16, 2016
Reprint of "Steroid 5α-reductase 2 deficiency"Berenice B Mendonca, Rafael Loch Batista, Sorahia Domenice, et al.Transactions of the American Clinical and Climatological Association|January 11, 2013
Sickle cell disease (SCD), iNKT cells, and regadenoson infusionDavid G Nathan, Joshua Field, Gene Lin, et al.Blood|April 17, 2010
Pulmonary hypertension and nitric oxide depletion in sickle cell diseaseH Franklin Bunn, David G Nathan, George J Dover, et al.Endocrinology|January 23, 2003
5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediateJean D Wilson, Richard J Auchus, Michael W Leihy, et al.The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual developmentMiroslav Dumic, Karen Lin-Su, Natasha I Leibel, et al.Blood|February 5, 2013
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenosonJoshua J Field, Gene Lin, Maureen M Okam, et al.The Journal of Clinical Investigation|October 19, 2004
Blasts from the pastPaul A Insel, Stuart Kornfeld, Philip W Majerus, et al.The Journal of Clinical Investigation|June 19, 2012
Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemiaVijay G Sankaran, Roxanne Ghazvinian, Ron Do, et al.Lancet (London, England)|May 16, 2003
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trialEric Nisbet-Brown, Nancy F Olivieri, Patricia J Giardina, et al.Blood Advances|January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J Field, Elaine Majerus, Victor R Gordeuk, et al.Pageof 7